11 results
Keyword panitumumab Remove keyword
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Vectibix
panitumumab, Colorectal Neoplasms
Date of authorisation: 03/12/2007, Revision: 31, Authorised, Last updated: 24/01/2020authorisation for Vectibix (panitumumab) Outcome of re-examination … contains the active substance panitumumab. Vectibix is used to treat … authorisation for Vectibix (panitumumab) EMA/CHMP/486351/2011 … -
List item
Human medicine European public assessment report (EPAR): Erbitux
cetuximab, Head and Neck Neoplasms, Colorectal Neoplasms
Date of authorisation: 29/06/2004, Revision: 28, Authorised, Last updated: 30/01/2020 -
List item
Human medicine European public assessment report (EPAR): Lonsurf
trifluridine, tipiracil hydrochloride, Colorectal Neoplasms
Date of authorisation: 25/04/2016,
, Revision: 5, Authorised, Last updated: 19/05/2020
-
List item
Human medicine European public assessment report (EPAR): Hemlibra
Emicizumab, Hemophilia A
Date of authorisation: 23/02/2018,, 
, Revision: 6, Authorised, Last updated: 16/09/2020
-
List item
Human medicine European public assessment report (EPAR): Zaltrap
aflibercept, Colorectal Neoplasms
Date of authorisation: 01/02/2013, Revision: 8, Authorised, Last updated: 12/11/2019 -
List item
Human medicine European public assessment report (EPAR): Portrazza
necitumumab, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 15/02/2016,, Revision: 2, Authorised, Last updated: 05/12/2016
-
List item
Human medicine European public assessment report (EPAR): Stivarga
regorafenib, Colorectal Neoplasms
Date of authorisation: 26/08/2013, Revision: 15, Authorised, Last updated: 15/10/2019 -
List item
Human medicine European public assessment report (EPAR): Cyramza
Ramucirumab, Stomach Neoplasms
Date of authorisation: 19/12/2014, Revision: 11, Authorised, Last updated: 02/07/2020 -
List item
Human medicine European public assessment report (EPAR): Tyverb
lapatinib, Breast Neoplasms
Date of authorisation: 10/06/2008, Revision: 30, Authorised, Last updated: 15/10/2019 -
List item
Human medicine European public assessment report (EPAR): Fanaptum
iloperidone, Schizophrenia
Date of refusal: 15/01/2018, Refused, Last updated: 19/03/2018 -
List item
Human medicine European public assessment report (EPAR): Human IGG1 monoclonal antibody specific for human interleukin-1 alpha XBiotech
human IgG1 monoclonal antibody specific for human interleukin-1 alpha, Colorectal Neoplasms
Date of refusal: 08/12/2017, Refused, Last updated: 13/11/2017